Literature DB >> 11475889

[Phytotherapeutic aspects of diseases of the circulatory system. 7. Schisandra chinensis (Turcz.) Baill.): its composition and biological activity].

L Opletal1, M Krenková, P Havlícková.   

Abstract

Schisandra chinensis (TURCZ.) BAILL., originally a Japanese-Manchurian endemite, yields a vegetable drug (Schisandrae fructus) with a number of very utilizable therapeutic effects. The paper reports the results of phytochemical and pharmacological-toxicological studies approximately from the year 1990 carried out both with the drug and, in particular, the principal isolated lignans of the dibenzo[a,c]cyclooctadiene type. The results confirm the validity of the historical use of the drug, in particular as a hepatoprotective, adaptogenic, and antioxidative agent. It is obvious that a very positive therapeutic effect based on the use of a complex mixture of its principal constituents because their biological effects are complementary and potentiate each other. At the same time, some lignans (e.g. gomisin A, gomisin N) are interesting as new prospective medicines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475889

Source DB:  PubMed          Journal:  Ceska Slov Farm        ISSN: 1210-7816


  2 in total

1.  Schizandra arisanensis extract attenuates cytokine-mediated cytotoxicity in insulin-secreting cells.

Authors:  Yi-Shin Hsu; Yao-Haur Kuo; Hui-Ling Cheng; Peter R Flatt; Hui-Kang Liu
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

2.  Schisandra chinensis peptidoglycan-assisted transmembrane transport of lignans uniquely altered the pharmacokinetic and pharmacodynamic mechanisms in human HepG2 cell model.

Authors:  Charng-Cherng Chyau; Yaw-Bee Ker; Chi-Huang Chang; Shiau-Huei Huang; Hui-Er Wang; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.